### 1 

### Appendix 5: Draft Detaile d Risk Modeling Results

### 2 Table 1 - Facility Identification Information

Source Category Facility NEI ID Facili ty Name Address City State
Secondary Lead NEI117 EAST PENN MFG CO INC/SMELTER PLT DEKA RD PO BOX 147 LYON STATION PA Secondary Lead NEI18383 SANDERS LEAD CO 100 SANDERS RD TROY AL Secondary Lead NEI21201 QUEMETCO INC 720 S 7TH AV INDUSTRY CA Secondary Lead NEI26338 GULF COAST RECYCLING, INC. 1901 N 66TH STREET TAMPA FL
Secondary Lead NEI2CA124838 EXIDE CORPORATION 2700 SOUTH INDIANA STREET VERNON CA
Secondary Lead NEI31400 EXIDE TECHNOLOGIES 2601 WEST MT PLEASANT BLVD MUNCIE IN
Secondary Lead NEI32182 QUEMETCO, INC. 7870 W. MORRIS STREET INDIANAPOLIS IN Secondary Lead NEI34021 GOPHER RESOURCE CORP 3385 S HIGHWAY 149 EAGAN MN
Secondary Lead NEI34270 EXIDE TECHNOLOGIES-CANON HOLLOW PLANT 111 CANON HOLLOW ROAD FOREST CITY MO
Secondary Lead NEI38394 REVERE SMELTING & REFINING CORP 65 BALLARD RD MIDDLETOWN NY
Secondary Lead NEI40662 EXIDE TECH/READING SMELTER 2ND & WASHINGTON ST READING PA Secondary Lead NEI6493 FRISCO BATTERY RECYCLI NG 7471 S FIFTH ST FRISCO TX
Secondary Lead NEILAT$10672 EXIDE TECHNOLOGIES/B R SMELTER 2400 BROOKLAWN DR BATON ROUGE LA Secondary Lead NEIMO0930005 DOE RUN COMPANY-BUICK MILL HIGHWAY KK BOSS MO

### 3 Table 2 – Maximum Predicted HEM-3 Chronic Risks

Facility NEI ID Source Category Chronic Risk 1

Cancer

MIR Cancer Incidence Noncancer Max HI Target Organ

Baseline scenario NEI117 7.63E-06 1.76E-04 9.03E-02 developmental NEI18383 4.42E-05 7.21E-04 5.37E-01 kidney NEI21201 5.95E-06 1.34E-03 7.54E-02 kidney NEI26338 1.24E-05 1.95E-03 1.32E-01 kidney NEI2CA124838 7.69E-06 8.13E-03 9.58E-02 kidney NEI31400 2.00E-06 1.52E-04 2.43E-02 developmental NEI32182 2.00E-06 8.28E-04 2.89E-02 developmental NEI34021 1.52E-05 7.06E-04 1.92E-01 kidney NEI34270 4.72E-06 2.70E-05 6.66E-02 respiratory NEI38394 7.57E-06 4.48E-04 1.06E-01 developmental NEI40662 4.79E-05 1.16E-03 5.89E-01 developmental NEI6493 4.45E-05 1.73E-03 5.00E-01 developmental NEILAT$10672 1.33E-06 6.33E-04 1.63E-02 respiratory NEIMO0930005 3.93E-05 8.20E-04 4.78E-01 developmental
Control Scenario NEI117 2.01E-06 7.00E-05 2.50E-02 developmental NEI18383 4.54E-06 1.98E-04 1.19E-01 respiratory NEI21201 5.95E-06 1.34E-03 7.54E-02 kidney NEI26338 2.73E-06 1.32E-03 5.68E-02 respiratory NEI2CA124838 3.20E-06 4.23E-03 3.85E-02 kidney NEI31400 7.12E-07 7.95E-0 5 9.40E-03 developmental NEI32182 1.93E-06 8.13E-04 2.81E-02 developmental NEI34021 3.17E-06 2.85E-04 3.86E-02 kidney NEI34270 1.78E-06 1.85E-05 6.16E-02 respiratory NEI38394 7.37E-06 4.43E-04 1.04E-01 developmental NEI40662 1.24E-05 4.92E-04 1.76E-01 developmental NEI6493 8.68E-06 1.01E-03 1.42E-01 respiratory NEILAT$10672 2 6.94E-07 4.35E-04 1.52E-02 respiratory NEIMO0930005 2 8.57E-06 4.51E-04 1.20E-01 developmental

1 BOLD indicates cancer risk greater than 1 in a million or noncancer risk greater than 1 2 Results presented for the control scenario do not reflect additional reductions in risk expected from stack emission limits that would affect this facility

### 4 Table 3 – Maximum Predicted Acute Risks by Facility

Facility NEI ID Pollutant Criteria HEM-3 (Screening) (Baseline) HEM-3 (Screening) (Controlled) Refined Results 1 (Controlled) NEI117 Arsenic compounds REL 0.6 0.4 NEI18383 Arsenic compounds REL 4.5 0.5 NEI21201 Arsenic compounds REL 0.5 0.5 NEI26338 Arsenic compounds REL 0.8 0.3 NEI2CA124838 Arsenic compounds REL 2.4 1.1 NEI31400 Arsenic compounds REL 1.0 0.4 NEI32182 Arsenic compounds REL 1.2 1.2 NEI34021 Arsenic compounds REL 1.6 0.4 NEI34270 Arsenic compounds REL 3.4 0.3 NEI38394 Arsenic compounds REL 5.5 5.4 4.8 NEI40662 Arsenic compounds REL 1.7 1.2 NEI6493 Arsenic compounds REL 3.9 0.9 NEILAT$10672 2 Arsenic compounds REL 30.0 2.9 0.6 NEIMO0930005 2 Arsenic compounds REL 19.8 1.4

1 Facilities with a HEM-3 screening controlled value great er than 1 were refined by examining results for maximum off-site impacts, see Appendix 6 for figures depicting off-site impacts

2 Screening controlled results also reflect reductions in risk expected from stack emission limits that would affect this facility

### 5 Table 4 – Maximum Predicted Lead Risks by Facility

Facility NEI ID Concentration is X times higher than the NAAQS (Baseline) Concentration is X times higher than the NAAQS (Controlled) NEI117 0.7 0.1 NEI18383 19 1 NEI21201 1.5 1.5 NEI26338 5 0.4 NEI2CA124838 10 4.3 NEI31400 1.3 0.3 NEI32182 0.6 0.5 NEI34021 3 0.7 NEI34270 4 0.3 NEI38394 1.4 1.1 NEI40662 4 0.5 NEI6493 3 0.4 NEILAT$10672 1 6 3.9 2
NEIMO0930005 1 23 1.5 1 Screening controlled results do not include reductions in risk expected from emission limits on stacks that would affect this facility. 2 Considering reductions in stack emissions, esti mated modeled ambient lead concentrations resulting from NEILAT$10672 

### are less than the NAAQS for lead.